Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Academic Staff Satisfaction with their Work: A Cross-Sectional Study in a Medical University.

Dimova R, Stoyanova R, Harizanova S, Tarnovska M, Keskinova D.

Open Access Maced J Med Sci. 2019 Jul 25;7(14):2384-2390. doi: 10.3889/oamjms.2019.657. eCollection 2019 Jul 30.

2.

New Poly(Propylene Imine) Dendrimer Modified with Acridine and Its Cu(II) Complex: Synthesis, Characterization and Antimicrobial Activity.

Bosch P, Staneva D, Vasileva-Tonkova E, Grozdanov P, Nikolova I, Kukeva R, Stoyanova R, Grabchev I.

Materials (Basel). 2019 Sep 18;12(18). pii: E3020. doi: 10.3390/ma12183020.

3.

Eco-compatible oxides enabling energy storage via Li+/Mg2+ co-intercalation.

Veleva S, Ivanova S, Półrolniczak P, Wasiński K, Nihtianova D, Stoyanova AE, Stoyanova R.

Dalton Trans. 2019 Sep 28;48(36):13641-13650. doi: 10.1039/c9dt02966d. Epub 2019 Aug 29.

PMID:
31464311
4.

Comparing patient safety culture in Bulgarian, Croatian and American hospitals - preliminary results.

Stoyanova R, Dimova R, Tarnovska M, Boeva T, Dimov R, Doykov I.

Med Pharm Rep. 2019 Jul;92(3):265-270. doi: 10.15386/mpr-1267. Epub 2019 Jul 31.

5.

Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesions.

Soodana-Prakash N, Castillo RP, Reis IM, Stoyanova R, Kwon D, Velasquez MC, Nahar B, Kannabur P, Johnson TA, Swain SK, Ben-Yakar N, Venkatramani V, Ritch C, Satyanarayana R, Gonzalgo ML, Parekh DJ, Bittencourt L, Punnen S.

Can J Urol. 2019 Jun;26(3):9763-9768.

PMID:
31180306
6.

Editorial Comment.

Stoyanova R.

J Urol. 2019 Sep;202(3):505. doi: 10.1097/01.JU.0000558544.57355.da. Epub 2019 Aug 8. No abstract available.

PMID:
31166884
7.

Academic Staff's Opinion on Their Job Satisfaction.

Dimova R, Stoyanova R, Harizanova S, Tarnovska M, Keskinova D.

Iran J Public Health. 2019 Apr;48(4):770-772. No abstract available.

8.

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.

Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y.

Oncotarget. 2019 Mar 12;10(21):2113. doi: 10.18632/oncotarget.26802. eCollection 2019 Mar 12.

9.

Classification of suspicious lesions on prostate multiparametric MRI using machine learning.

Kwon D, Reis IM, Breto AL, Tschudi Y, Gautney N, Zavala-Romero O, Lopez C, Ford JC, Punnen S, Pollack A, Stoyanova R.

J Med Imaging (Bellingham). 2018 Jul;5(3):034502. doi: 10.1117/1.JMI.5.3.034502. Epub 2018 Sep 6.

10.

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.

Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y.

Oncotarget. 2018 Dec 14;9(98):37125-37136. doi: 10.18632/oncotarget.26437. eCollection 2018 Dec 14. Erratum in: Oncotarget. 2019 Mar 12;10(21):2113. Parra, Andres N [corrected to Parra, N Andres].

11.

Do Personality Characteristics Constitute the Profile of Burnout-Prone Correctional Officers?

Harizanova S, Stoyanova R, Mateva N.

Open Access Maced J Med Sci. 2018 Oct 12;6(10):1912-1917. doi: 10.3889/oamjms.2018.328. eCollection 2018 Oct 25.

12.

Automatic Detection of Prostate Tumor Habitats using Diffusion MRI.

Tschudi Y, Pollack A, Punnen S, Ford JC, Chang YC, Soodana-Prakash N, Breto AL, Kwon D, Munera F, Abramowitz MC, Kryvenko ON, Stoyanova R.

Sci Rep. 2018 Nov 14;8(1):16801. doi: 10.1038/s41598-018-34916-4.

13.

Entering an era of radiogenomics in prostate cancer risk stratification.

Soodana-Prakash N, Stoyanova R, Bhat A, Velasquez MC, Kineish OE, Pollack A, Parekh DJ, Punnen S.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S443-S452. doi: 10.21037/tau.2018.07.04. Review.

14.
15.

Towards a universal MRI atlas of the prostate and prostate zones : Comparison of MRI vendor and image acquisition parameters.

Padgett KR, Swallen A, Pirozzi S, Piper J, Chinea FM, Abramowitz MC, Nelson A, Pollack A, Stoyanova R.

Strahlenther Onkol. 2019 Feb;195(2):121-130. doi: 10.1007/s00066-018-1348-5. Epub 2018 Aug 23.

PMID:
30140944
16.

Reply to letter to the editor titled "Methodological issue on mixed-methods study of reported clinical cases of undesirable events, medical errors, and near misses in health care".

Dimova R, Stoyanova R, Doykov I.

J Eval Clin Pract. 2018 Aug;24(4):785-786. doi: 10.1111/jep.13008. No abstract available.

PMID:
30117662
17.

Lithium versus Mono/Polyvalent Ion Intercalation: Hybrid Metal Ion Systems for Energy Storage.

Stoyanova R, Koleva V, Stoyanova A.

Chem Rec. 2019 Feb;19(2-3):474-501. doi: 10.1002/tcr.201800081. Epub 2018 Aug 17. Review.

PMID:
30117651
18.

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer.

Punnen S, Nahar B, Soodana-Prakash N, Koru-Sengul T, Stoyanova R, Pollack A, Kava B, Gonzalgo ML, Ritch CR, Parekh DJ.

PLoS One. 2018 Aug 9;13(8):e0201384. doi: 10.1371/journal.pone.0201384. eCollection 2018.

19.

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.

Yang F, Ford JC, Dogan N, Padgett KR, Breto AL, Abramowitz MC, Dal Pra A, Pollack A, Stoyanova R.

Transl Androl Urol. 2018 Jun;7(3):445-458. doi: 10.21037/tau.2018.06.05. Review.

20.

Contemporary role of postoperative radiotherapy for prostate cancer.

Dal Pra A, Abramowitz MC, Stoyanova R, Pollack A.

Transl Androl Urol. 2018 Jun;7(3):399-413. doi: 10.21037/tau.2018.06.01. Review.

21.

Mixed-methods study of reported clinical cases of undesirable events, medical errors, and near misses in health care.

Dimova R, Stoyanova R, Doykov I.

J Eval Clin Pract. 2018 Aug;24(4):752-757. doi: 10.1111/jep.12970. Epub 2018 Jun 26.

PMID:
29947085
22.

Radiomics and radiogenomics of prostate cancer.

Smith CP, Czarniecki M, Mehralivand S, Stoyanova R, Choyke PL, Harmon S, Turkbey B.

Abdom Radiol (NY). 2019 Jun;44(6):2021-2029. doi: 10.1007/s00261-018-1660-7.

PMID:
29926137
23.

An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes.

Stoyanova R, Chinea F, Kwon D, Reis IM, Tschudi Y, Parra NA, Breto AL, Padgett KR, Pra AD, Abramowitz MC, Kryvenko ON, Punnen S, Pollack A.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):821-829. doi: 10.1016/j.ijrobp.2018.06.003. Epub 2018 Jun 13.

PMID:
29908220
24.

Evaluation of radiomic texture feature error due to MRI acquisition and reconstruction: A simulation study utilizing ground truth.

Yang F, Dogan N, Stoyanova R, Ford JC.

Phys Med. 2018 Jun;50:26-36. doi: 10.1016/j.ejmp.2018.05.017. Epub 2018 May 22.

PMID:
29891091
25.

Linguistic Validation and Cultural Adaptation of Bulgarian Version of Hospital Survey on Patient Safety Culture (HSOPSC).

Stoyanova R, Dimova R, Tarnovska M, Boeva T.

Open Access Maced J Med Sci. 2018 May 18;6(5):925-930. doi: 10.3889/oamjms.2018.222. eCollection 2018 May 20.

26.

Analysis of Magnetic Resonance Image Signal Fluctuations Acquired During MR-Guided Radiotherapy.

Breto AL, Padgett KR, Ford JC, Kwon D, Chang C, Fuss M, Stoyanova R, Mellon EA.

Cureus. 2018 Mar 28;10(3):e2385. doi: 10.7759/cureus.2385.

27.

Daily Tracking of Glioblastoma Resection Cavity, Cerebral Edema, and Tumor Volume with MRI-Guided Radiation Therapy.

Mehta S, Gajjar SR, Padgett KR, Asher D, Stoyanova R, Ford JC, Mellon EA.

Cureus. 2018 Mar 19;10(3):e2346. doi: 10.7759/cureus.2346.

28.

Redox properties of alluaudite sodium cobalt manganese sulfates as high-voltage electrodes for rechargeable batteries.

Marinova DM, Kostov VV, Nikolova RP, Kukeva RR, Zhecheva EN, Stoyanova RK.

Chem Commun (Camb). 2018 May 24;54(43):5466-5469. doi: 10.1039/c8cc01922c.

PMID:
29749409
29.

Selective sodium intercalation into sodium nickel-manganese sulfate for dual Na-Li-ion batteries.

Marinova DM, Kukeva RR, Zhecheva EN, Stoyanova RK.

Phys Chem Chem Phys. 2018 May 9;20(18):12755-12766. doi: 10.1039/c8cp01667d.

PMID:
29697732
30.

Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis.

Padgett KR, Stoyanova R, Pirozzi S, Johnson P, Piper J, Dogan N, Pollack A.

J Appl Clin Med Phys. 2018 Mar;19(2):258-264. doi: 10.1002/acm2.12296. Epub 2018 Feb 23.

31.

Economic costs due to workers' sick leave at wastewater treatment plants in Bulgaria.

Toseva EI, Stoyanova R, Turnovska T.

Med Pr. 2018 Mar 9;69(2):129-141. doi: 10.13075/mp.5893.00577. Epub 2018 Jan 12.

32.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL.

J Clin Oncol. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940. Epub 2017 Nov 29.

33.

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness.

Parra NA, Pollack A, Chinea FM, Abramowitz MC, Marples B, Munera F, Castillo R, Kryvenko ON, Punnen S, Stoyanova R.

Front Oncol. 2017 Nov 10;7:259. doi: 10.3389/fonc.2017.00259. eCollection 2017.

34.

Spectral decomposition for resolving partial volume effects in MRSI.

Goryawala MZ, Sheriff S, Stoyanova R, Maudsley AA.

Magn Reson Med. 2018 Jun;79(6):2886-2895. doi: 10.1002/mrm.26991. Epub 2017 Nov 11.

35.

Combined use of EPR and 23Na MAS NMR spectroscopy for assessing the properties of the mixed cobalt-nickel-manganese layers of P3-NayCo1-2xNixMnxO2.

Kalapsazova M, Ivanova S, Kukeva R, Simova S, Wegner S, Zhecheva E, Stoyanova R.

Phys Chem Chem Phys. 2017 Oct 11;19(39):27065-27073. doi: 10.1039/c7cp04849a.

PMID:
28959996
36.

Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.

Chang YC, Ackerstaff E, Tschudi Y, Jimenez B, Foltz W, Fisher C, Lilge L, Cho H, Carlin S, Gillies RJ, Balagurunathan Y, Yechieli RL, Subhawong T, Turkbey B, Pollack A, Stoyanova R.

Sci Rep. 2017 Aug 29;7(1):9746. doi: 10.1038/s41598-017-09932-5.

37.

Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.

Han S, Stoyanova R, Lee H, Carlin SD, Koutcher JA, Cho H, Ackerstaff E.

Magn Reson Med. 2018 Mar;79(3):1736-1744. doi: 10.1002/mrm.26822. Epub 2017 Jul 20.

38.

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

Nguyen PL, Haddad Z, Ross AE, Martin NE, Deheshi S, Lam LLC, Chelliserry J, Tosoian JJ, Lotan TL, Spratt DE, Stoyanova RS, Punnen S, Ong K, Buerki C, Aranes M, Kolisnik T, Margrave J, Yousefi K, Choeurng V, Davicioni E, Trock BJ, Kane CJ, Pollack A, Davis JW, Feng FY, Klein EA.

Eur Urol. 2017 Nov;72(5):845-852. doi: 10.1016/j.eururo.2017.05.009. Epub 2017 May 19.

39.

Crystal chemistry of Mg substitution in NaMnPO4 olivine: concentration limit and cation distribution.

Boyadzhieva T, Koleva V, Stoyanova R.

Phys Chem Chem Phys. 2017 May 24;19(20):12730-12739. doi: 10.1039/c7cp01947e.

PMID:
28492685
40.

Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.

Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R.

J Natl Cancer Inst. 2017 Feb 1;109(2):1-8. doi: 10.1093/jnci/djw232.

41.

The EUROPEP questionnaire for patient's evaluation of general practice care: Bulgarian experience.

Dimova R, Stoyanova R, Keskinova D.

Croat Med J. 2017 Feb 28;58(1):63-74.

42.

Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.

Lopez CJ, Nagornaya N, Parra NA, Kwon D, Ishkanian F, Markoe AM, Maudsley A, Stoyanova R.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):586-595. doi: 10.1016/j.ijrobp.2016.11.011. Epub 2016 Nov 15.

43.

Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.

Parra NA, Orman A, Padgett K, Casillas V, Punnen S, Abramowitz M, Pollack A, Stoyanova R.

Strahlenther Onkol. 2017 Jan;193(1):13-21. doi: 10.1007/s00066-016-1055-z. Epub 2016 Oct 19.

44.

Prostate cancer radiomics and the promise of radiogenomics.

Stoyanova R, Takhar M, Tschudi Y, Ford JC, Solórzano G, Erho N, Balagurunathan Y, Punnen S, Davicioni E, Gillies RJ, Pollack A.

Transl Cancer Res. 2016 Aug;5(4):432-447.

45.

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Stoyanova R, Pollack A, Takhar M, Lynne C, Parra N, Lam LL, Alshalalfa M, Buerki C, Castillo R, Jorda M, Ashab HA, Kryvenko ON, Punnen S, Parekh DJ, Abramowitz MC, Gillies RJ, Davicioni E, Erho N, Ishkanian A.

Oncotarget. 2016 Aug 16;7(33):53362-53376. doi: 10.18632/oncotarget.10523.

46.

Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.

Obeid JP, Stoyanova R, Kwon D, Patel M, Padgett K, Slingerland J, Takita C, Alperin N, Yepes M, Zeidan YH.

Clin Transl Oncol. 2017 Feb;19(2):211-218. doi: 10.1007/s12094-016-1526-9. Epub 2016 Jun 30.

PMID:
27364695
47.

Layered P3-NaxCo1/3Ni1/3Mn1/3O2 versus Spinel Li4Ti5O12 as a Positive and a Negative Electrode in a Full Sodium-Lithium Cell.

Ivanova S, Zhecheva E, Kukeva R, Nihtianova D, Mihaylov L, Atanasova G, Stoyanova R.

ACS Appl Mater Interfaces. 2016 Jul 13;8(27):17321-33. doi: 10.1021/acsami.6b05075. Epub 2016 Jun 28.

PMID:
27315402
48.

Denoising of MR spectroscopic imaging data using statistical selection of principal components.

Abdoli A, Stoyanova R, Maudsley AA.

MAGMA. 2016 Dec;29(6):811-822. Epub 2016 Jun 3.

49.

Quantification of the margin required for treating intraprostatic lesions.

Studenski MT, Valenciaga Y, Abramowitz MC, Stoyanova R, Bossart E, Dogan N, Pollack A.

J Appl Clin Med Phys. 2016 May 8;17(3):304-312. doi: 10.1120/jacmp.v17i3.6089.

50.

Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer.

Bossart EL, Stoyanova R, Sandler K, Studenski M, Orman A, Abramowitz M, Pollack A.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):827-34. doi: 10.1016/j.ijrobp.2016.01.052. Epub 2016 Feb 4.

PMID:
27020109

Supplemental Content

Loading ...
Support Center